Arch Fam Med
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 1 No. 2, November 1992 TABLE OF CONTENTS
  •  Online Features
  Clinical Reviews
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Benign Prostatic Hyperplasia

Its Natural History, Epidemiologic Characteristics, and Surgical Treatment

Joseph E. Oesterling, MD

Arch Fam Med. 1992;1(2):257-266.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Walsh PC. Human benign prostatic hyperplasia: etiological considerations. Prog Clin Biol Res. 1984;145:1-25. PUBMED
2. Schröder FH, Blom JHM. Natural history of benign prostatic hyperplasia (BPH). Prostate. 1989;(suppl_2):17-22.
3. Ekman P. BPH epidemiology and risk factors. Prostate. 1989;2(suppl):23-31. PUBMED
4. Birkhoff JD. Natural history of benign prostatic hypertrophy. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:5-9.
5. Kane MM, Fields DW, Vaughan ED Jr. Medical management of benign prostatic hyperplasia. Urology. 1990;36(suppl):5-12. PUBMED
6. Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1987. Vital Health Stat. 1989;100:295.
7. Graversen PH, Gasser TC, Wasson JH, Hinman F Jr, Bruskewitz RC. Controversies about indications for transurethral resection of the prostate. J Urol. 1989;141:475-481. PUBMED
8. Nielsen KT, Christensen MM, Madsen PO, Bruskewitz RC. Symptom analysis and uroflowmetry 7 years after transurethral resection of the prostate. J Urol. 1989;142:1251-1253. PUBMED
9. Roos NP, Ramsey EW. A population-based study of prostatectomy: outcomes associated with differing surgical approaches. J Urol. 1987;137:1184-1188. PUBMED
10. Roos NP, Wennberg JE, Malenka DJ, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320:1120-1124. ABSTRACT
11. Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate. 1989;(suppl 2):33-50.
12. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy: the Baltimore Longitudinal Study of Aging. Urology. 1991;38(suppl):4-8. PUBMED
13. Guess HA, Arrighi HM, Metter EJ, Fozard JL. Cumulative prevalence of prostatism matches the autopsy prevalence of benign prostatic hyperplasia. Prostate. 1990;17:241-260. PUBMED
14. Franks LM. Benign nodular hyperplasia of the prostate: a review. Ann R Coll Surg Engl. 1954;14:92-106. PUBMED
15. Ahluwalia MS, Tandon HD. Nodular hyperplasia of the prostate in North India: an autopsy study. J Urol. 1965;93:94-101. PUBMED
16. Pradhan BK, Chandra K. Morphogenesis of nodular hyperplasia: prostate. J Urol. 1975;113:210-213. PUBMED
17. Bartsch G, Müller HR, Oberholzer M, Rohr HP. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol. 1979;122:487-491. PUBMED
18. Bartsch G, Frick J, Rüegg I, et al. Electron microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia. J Urol. 1979;122:481-486. PUBMED
19. Lawson RK. The natural history of benign prostatic hyperplasia. AUA Update Ser. 1986;5 (lesson 19):1-8.
20. Moore RA. Benign hypertrophy of the prostate: a morphological study. J Urol. 1943;50:680-710.
21. Swyer GIM. Post-natal growth changes in the human prostate. J Anat. 1944;78:130-145. PUBMED
22. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132:474-479. PUBMED
23. Harbitz TB, Haugen OA. Histology of the prostate in elderly men: a study in an autopsy series. Acta Pathol Microbiol Scand A. 1972;80:756-768. PUBMED
24. Hølund B. Latent prostatic cancer in a consecutive autopsy series. Scand J Urol Nephrol. 1980;14:29-35. PUBMED
25. Hubly JW, Thompson GJ. Infarction of the prostate and volumetric changes produced by the lesion: report of three cases. J Urol. 1940;43:459-467.
26. Spiro LH, Labay G, Orkin LA. Prostatic infarction: role in acute urinary retention. Urology. 1974;3:345-347. PUBMED
27. Hinman F Jr. Capsular influence on benign prostatic hyperplasia. Urology. 1986;28:347-350. PUBMED
28. Watanabe H. Natural history of benign prostatic hypertrophy. Ultrasound Med Biol. 1986;12:567-571. PUBMED
29. Clarke R. The prostate and the endocrines: a control series. Br J Urol. 1937;9:254-271.
30. Craigen AA, Hickling JB, Saunders CRG, Carpenter RG. Natural history of prostatic obstruction: a prospective survey. J R Coll Gen Pract. 1969;18:226-232. PUBMED
31. Birkhoff JD, Wiederhorn AR, Hamilton ML, Zinsser HH. Natural history of benign prostatic hypertrophy and acute urinary retention. Urology. 1976;7:48-52. PUBMED
32. Ball AJ, Feneley RCL, Abrams PH. The natural history of untreated 'prostatism.' Br J Urol. 1981;53:613-616. PUBMED
33. Barnes RW, Marsh C. Progression of obstruction and symptoms. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:711-713.
34. Barry MJ. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am. 1990;17:495-507. PUBMED
35. Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC. Influence of age and endocrine factors on the volume of benign prostatic hyperplasia. J Urol. 1991;145:405-409. PUBMED
36. Scott WW. What makes the prostate grow. J Urol. 1953;70:477-488. PUBMED
37. Van der Reis L. Benign prostatic hypertrophy and coronary heart disease: correlation or coincidence? J Am Geriatr Soc. 1959;7:866-869. PUBMED
38. Rotkin ID. Epidemiology of benign prostatic hypertrophy: review and speculations. In: NIAMDD Workshop Proceedings. Washington, DC: US Government Printing Office; 1975:105-117.
39. Roberts HJ. The role of diabetogenic hyperinsulinism in the pathogenesis of prostatic hyperplasia and malignancy. J Am Geriatr Soc. 1966;14:795-825. PUBMED
40. Bourke JB, Griffin JP. Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy. Br J Urol. 1966;38:18-23. PUBMED
41. Lytton B, Emery JM, Harvard BM. The incidence of benign prostatic obstruction. Trans Am Assoc Genitourin Surg. 1967;59:65-71.
42. Armenian HK, Lilienfeld AM, Diamond EL, Bross IDJ. Relation between benign prostatic hyperplasia and cancer of the prostate: a prospective and retrospective study. Lancet. 1974;2:115-117. PUBMED
43. Greenwald P, Kirmss V, Polan AK, Dick VS. Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst. 1974;53:335-340. PUBMED
44. Finkle AL. The relationship of sexual habits to benign prostatic hypertrophy. Med Aspects Hum Sex. 1967;1:24-25. PUBMED
45. Araki H, Watanabe H, Mishina T, Nakao M. High-risk group for benign prostatic hypertrophy. Prostate. 1983;4:253-264. PUBMED
46. Oishi K, Okada K, Yoshida O, et al. A case-control study of prostatic cancer with reference to dietary habits. Prostate. 1988;12:179-190. PUBMED
47. Chang HL, Char GY. Benign hypertrophy of prostate. Chin Med J. 1936;50:1707-1722.
48. Conger KB. Racial incidence of prostatism in Hawaii: a report of 172 consecutive cases. J Urol. 1947;58:444-447.
49. Karube K. Study of latent carcinoma of the prostate in the Japanese based on necropsy material. Tohoku J Exp Med. 1961;74:265-285. PUBMED
50. Tan RE. Prostatic disease in Indonesia. J Urol. 1961;86:428-430. PUBMED
51. Fay R. Prostatic obstruction in Chinese populations. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:27-29.
52. Incidence of prostatic enlargement among 6975 males. Proc Life Extension Examiners. 1940;2:92-94.
53. Randall A. Surgical Pathology of Prostatic Obstructions. Baltimore, Md: Williams & Wilkins; 1931.
54. Husain I, Kazim EM. Urological evaluation of the tropical patient. In: Husain I, ed. Tropical Urology and Renal Disease. New York, NY: Churchill Livingstone Inc; 1984:11-46.
55. Holtgrewe HL, Mebust WK, Dowd JB, Cockett ATK, Peters PC, Proctor C. Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol. 1989;141:248-253. PUBMED
56. Gofin R. The health status of elderly men: a community study. Public Health. 1982;96:345-354. PUBMED
57. D'Aunoy R, Schenken JR, Burns EL. The relative incidence of hyperplasia of the prostate in the white and colored races in Louisiana: an analysis of 325 glands removed at operation. South Med J. 1939;32:47-52.
58. Derbes V deP, Leche SM, Hooker CW. The incidence of benign prostatic hypertrophy among the whites and Negroes in New Orleans. J Urol. 1937;38:383-388.
59. Lytton B, Emery JM, Harvard BM. The incidence of benign prostatic obstruction. J Urol. 1968;99:639-645. PUBMED
60. Sidney S, Quesenberry C Jr, Sadler MC, Lydick ED, Guess HA, Cattolica EV. Risk factors for surgically treated benign prostatic hyperplasia in a prepaid health care plan. Urology. 1991;38(suppl):13-19. PUBMED
61. Rotkin ID. Origins, distribution, and risk of benign prostatic hypertrophy. In: Hinman F Jr, Boyarsky S, eds. Benign Prostatic Hypertrophy. New York, NY: Springer-Verlag NY Inc; 1983:10-21.
62. Fowler FJ Jr, Wennberg JE, Timothy RP, Barry MJ, Mulley AG Jr, Hanley D. Symptom status and quality of life following prostatectomy. JAMA. 1988;259:3018-3022. FREE FULL TEXT
63. Barry MJ. Medical outcomes research and benign prostatic hyperplasia. Prostate. 1990;(suppl 3):61-74.
64. Barry MJ, Mulley AG Jr, Fowler FJ, Wennberg JW. Watchful waiting vs immediate transurethral resection for symptomatic prostatism: the importance of patients' preferences. JAMA. 1988;259:3010-3017. FREE FULL TEXT
65. Epstein RS, Lydick EG, deLabry L, Vokonas PS. Age-related differences in risk factors for prostatectomy for benign prostatic hyperplasia: the VA Normative Aging Study. Urology. 1991;38 (suppl):9-12. PUBMED
66. Mebust WK, Holtgrewe HL. Current status of transurethral prostatectomy: a review of the AUA National Cooperative Study. World J Urol. 1989;6:194-197.
67. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate. 1990;16:39-48. PUBMED
68. Janknegt RA. Surgical management for benign prostatic hyperplasia: indications, techniques, and results. Prostate. 1989;(suppl 2):79-93.
69. Chilton CP, Morgan RJ, England HR, Paris AMI, Blandy JP. A critical evaluation of the results of transurethral resection of the prostate. Br J Urol. 1978;50:542-546. PUBMED
70. Neal DE, Ramsden PD, Sharples L, et al. Outcome of elective prostatectomy. BMJ. 1989;299:762-767. FREE FULL TEXT
71. Wennberg JE, Roos N, Sola L, Schori A, Jaffe R. Use of claims data systems to evaluate health care outcomes: mortality and reoperation following prostatectomy. JAMA. 1987;257:933-936. FREE FULL TEXT
72. Stephenson WP, Chute CG, Guess HA, Schwartz S, Lieber M. Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester, Minnesota: 1980-1987; a population-based study. Urology. 1991;38(suppl): 32-42. PUBMED
73. Andersen TF, Brønnum-Hansen H, Sejr T, Roepstorff C. Elevated mortality following transurethral resection of the prostate for benign hypertrophy! but why? Med Care. 1990;28:870-879. PUBMED
74. Singh M, Tresidder GC, Blandy JP. The evaluation of transurethral resection for benign enlargement of the prostate. Br J Urol. 1973;45:93-102. PUBMED
75. Holtgrewe HL, Valk WL. Factors influencing the mortality and morbidity of transurethral prostatectomy: a study of 2015 cases. J Urol. 1962;87:450-459. PUBMED
76. Melchior J, Valk WL, Foret JD, Mebust WK. Transurethral prostatectomy: computerized analysis of 2223 consecutive cases. J Urol. 1974;112:634-642. PUBMED
77. Isaacs JT. Importance of the natural history of benign prostatic hyperplasia in the evaluation of pharmacologic intervention. Prostate. 1990;(suppl 3):1-7.
78. Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC, Writing Committee. Transurethral prostatectomy: immediate and postoperative complications—a cooperative study of 13 participating institutions evaluating 3885 patients. J Urol. 1989;141:243-247. PUBMED
79. Lubitz J, Riley G, Newton M. Outcomes of surgery among the Medicare aged: mortality after surgery. Health Care Financ Rev. 1985;6:103. PUBMED
80. Meyhoff HH, Nordling J. Long-term results of transurethal and transvesical prostatectomy: a randomized study. Scand J Urol Nephrol. 1986;20:27-33. PUBMED
81. Kolmert T, Norlén H. Transurethral resection of the prostate: a review of 1111 cases. Int Urol Nephrol. 1989;21:47-55. PUBMED
82. Lund B-L, Dingsør E. Benign obstructive prostatic enlargement: a comparison between the results of treatment by transurethral electroresection and the results of open surgery. Scand J Urol Nephrol. 1976;10:33-38. PUBMED
83. Gupta NP, Mohanty NK, Reddy PS, Wadhwa SN, Singh SM. A high risk factor score in the management of benign prostatic hyperplasia. Br J Urol. 1986;58:296-298. PUBMED
84. Møller-Nielsen C, Lundhus E, Møller-Madsen B, et al. Sexual life following 'minimal' and 'total' transurethral prostatic resection. Urol Int. 1985;40:3-4. PUBMED
85. Hargreave TB, Stephenson TP. Potency and prostatectomy. Br J Urol. 1977;49:683-688. PUBMED
86. Malone PR, Cook A, Edmonson R, Gill MW, Shearer RJ. Prostatectomy: patients' perception and long-term follow-up. Br J Urol. 1988;61:234-238. PUBMED
87. Holtgrewe HL, Valk WL. Late results of transurethral prostatectomy. J Urol. 1964;92:51-55. PUBMED
88. Jensen KM-E, Jørgensen JB, Mogensen P. Urodynamics in prostatism, I: prognostic value of uroflowmetry. Scand J Urol Nephrol. 1988;22:109-117. PUBMED
89. Lepor H, Rigaud G. The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism. J Urol. 1990;143:533-537. PUBMED
90. Bruskewitz RC, Larsen EH, Madsen PO, Dørflinger T. 3-year followup of urinary symptoms after transurethral resection of the prostate. J Urol. 1986;136:613-615. PUBMED
91. Ball AJ, Smith PJB. The long-term effects of prostatectomy: a uroflowmetric analysis. J Urol. 1982;128:538-539. PUBMED
92. Meyhoff HH, Nordling J, Hald T. Economy in transurethral prostatectomy. Scand J Urol Nephrol. 1985;19:17-20. PUBMED